Women undergoing the menopausal transition may be prone to prolonged bleeding with periods of heaviness, according to a new study in BJOG.
Women undergoing the menopausal transition may be prone to prolonged bleeding with periods of heaviness, according to a new study in BJOG.
Researchers from the University of Michigan School of Public Health and the University of Michigan Health System looked at 1320 midlife women from a variety of races who had participated in the Study of Women’s Health Across the Nation Menstrual Calendar Substudy. Each woman completed a daily menstrual calendar from 1996 to 2006 that included information about hormone therapy, smoking status, and the level of physical activities. Height and weight were measured every year. Primary outcomes examined included menses of 10-plus days, spotting of 6-plus days, and heavy bleeding of 3-plus days. Multivariable regression and Kaplan-Meier survival analysis were used to analyze the data.
In the cohort, 77.7% (95% confidence interval [CI] 56.7-93.2) reported at least 3 occurrences of menses of 10-plus days. At least 3 occurrences of 6-plus days of spotting were reported by 66.8% (95% CI 55.2 – 78.0) of the women and 34.5% (95% CI 30.2 – 39.2) reported at least 3 occurrences of 3-plus days of heavy bleeding. Each primary outcome was associated with uterine fibroids, hormone use, and ethnicity. Body mass index was associated with 3-plus days of heavy bleeding.
The investigators concluded that the study provided important information about how frequent spotting, prolonged bleeding, and heavy bleeding can be during the menopausal transition. They felt the data could help facilitate clinical decision-making during that time.
To get weekly advice for today's Ob/Gyn, subscribe to the Contemporary Ob/Gyn Special Delivery.
Study reveals critical gaps in care for PCOS patients
May 17th 2024A new study presented at the 2024 ACOG Annual Clinical and Scientific Meeting highlighted significant gaps in polycystic ovary syndrome (PCOS) care, revealing widespread patient dissatisfaction and the urgent need for improved provider education and comprehensive treatment approaches.
Read More
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
Impact of antiepileptic medications and sex hormones on maternal and child outcomes in epilepsy
May 16th 2024Paula Emanuela Voinescu, MD, PhD, director of the Women's Epilepsy Program at Brigham and Women's Hospital, talked about the influence of sex hormones on maternal outcomes in pregnant women with epilepsy treated with antiseizure medication.
Read More
Prenatal cannabis and nicotine use linked to adverse pregnancy outcomes
May 14th 2024A recent study highlights the heightened risks of maternal and neonatal morbidity and mortality associated with combined cannabis and nicotine use during pregnancy, urging further investigation into their impact on short- and long-term outcomes.
Read More
Echogenic Mass identified as key predictor for retained products of conception
May 13th 2024Discover how recent findings highlight the significance of echogenic masses in accurately diagnosing post-pregnancy complications, shedding light on effective management strategies and reducing the need for invasive interventions.
Read More